{"transactions":[{"id":4621402,"issuer":{"id":7054,"kind":"organization","name":"BioStem Technologies, Inc.","symbol":"BSEM"},"owners":[{"id":21226,"kind":"person","name":"POE BRANDON","position":1,"cik":"0002147189","reported_name":"POE BRANDON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-17T20:30:16.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":false,"shares":1694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024)."}],"balance_after":6775,"derivative":{"underlying":"Common Stock","underlying_shares":1694},"source":{"system":"sec-edgar","filing":"0001193125-26-394397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2147189/000119312526394397/ownership.xml","form_type":"4"}},{"id":4621401,"issuer":{"id":7054,"kind":"organization","name":"BioStem Technologies, Inc.","symbol":"BSEM"},"owners":[{"id":21226,"kind":"person","name":"POE BRANDON","position":1,"cik":"0002147189","reported_name":"POE BRANDON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-17T20:30:16.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":true,"shares":1694,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58062,"source":{"system":"sec-edgar","filing":"0001193125-26-394397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2147189/000119312526394397/ownership.xml","form_type":"4"}},{"id":679865,"issuer":{"id":7054,"kind":"organization","name":"BioStem Technologies, Inc.","symbol":"BSEM"},"owners":[{"id":21226,"kind":"person","name":"POE BRANDON","position":1,"cik":"0002147189","reported_name":"POE BRANDON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-20T23:30:05.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":false,"shares":10634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units vest according to the following schedule: 33% vested on August 11, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Due to an administrative error, the vesting of the restricted stock units was not timely reported on a Form 4 within two business days of the applicable transaction date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units vest according to the following schedule: 33% vested on August 11, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Due to an administrative error, the vesting of the restricted stock units was not timely reported on a Form 4 within two business days of the applicable transaction date."}],"balance_after":21591,"derivative":{"underlying":"Common Stock","underlying_shares":10634},"source":{"system":"sec-edgar","filing":"0002147189-26-000006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658678/000214718926000006/ownership.xml","form_type":"4"}},{"id":679864,"issuer":{"id":7054,"kind":"organization","name":"BioStem Technologies, Inc.","symbol":"BSEM"},"owners":[{"id":21226,"kind":"person","name":"POE BRANDON","position":1,"cik":"0002147189","reported_name":"POE BRANDON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-20T23:30:05.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":true,"shares":10634,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56368,"source":{"system":"sec-edgar","filing":"0002147189-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658678/000214718926000006/ownership.xml","form_type":"4"}}]}